• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬脾血管肉瘤细胞在体外表达和激活黄体生成素受体。

Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.

出版信息

Am J Vet Res. 2022 Nov 7;83(12):ajvr.22.07.0120. doi: 10.2460/ajvr.22.07.0120.

DOI:10.2460/ajvr.22.07.0120
PMID:36327166
Abstract

OBJECTIVE

To determine luteinizing hormone receptor (LHR) expression and response to LHR activation in isolated canine splenic hemangiosarcoma cell lines in vitro.

SAMPLES

In vitro cultures of commercially available canine splenic hemangiosarcoma cell lines (EFS, GRACE-HSA, and DAL-4).

PROCEDURES

The percentage of each cell line expressing LHR was determined by immunocytochemistry. Cells were then treated with increasing doses (7.5 ng/mL, 75 ng/mL) of recombinant canine luteinizing hormone (cLH) for 48 hours and evaluated using a cell proliferation assay.

RESULTS

The percentage of cells expressing LHR was 17.2 ± 4.5%, 11.8 ± 3.1%, and 6.9 ± 2.5% in EFS, GRACE-HSA, and DAL-4, respectively. There was significant increase in cell count in the DAL-4 and EFS cell lines following a 48-hour incubation at the highest cLH concentration (P = .028 and P = .019, respectively). There was not a significant increase in cell count in the GRACE-HSA cell line at either cLH concentration.

CLINICAL RELEVANCE

Activation of LHR results in cell proliferation in some canine splenic hemangiosarcoma cell lines. These results may explain why spayed and castrated dogs with high circulating LH concentrations may develop hemangiosarcoma more frequently than intact dogs.

摘要

目的

确定犬脾血管肉瘤细胞系中黄体生成素受体 (LHR) 的表达及其对 LHR 激活的反应。

样本

市售犬脾血管肉瘤细胞系 (EFS、GRACE-HSA 和 DAL-4) 的体外培养物。

过程

通过免疫细胞化学测定每种细胞系中 LHR 表达的百分比。然后用不同剂量(7.5ng/mL、75ng/mL)的重组犬促黄体激素(cLH)处理细胞 48 小时,并通过细胞增殖测定进行评估。

结果

EFS、GRACE-HSA 和 DAL-4 细胞系中 LHR 表达的细胞百分比分别为 17.2±4.5%、11.8±3.1%和 6.9±2.5%。在最高 cLH 浓度孵育 48 小时后,DAL-4 和 EFS 细胞系中的细胞计数显著增加(P=0.028 和 P=0.019)。在两种 cLH 浓度下,GRACE-HSA 细胞系中的细胞计数均无显著增加。

临床相关性

LHR 的激活导致一些犬脾血管肉瘤细胞系的细胞增殖。这些结果可能解释了为什么循环中 LH 浓度较高的去势和绝育犬比未绝育犬更频繁地发生血管肉瘤。

相似文献

1
Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.犬脾血管肉瘤细胞在体外表达和激活黄体生成素受体。
Am J Vet Res. 2022 Nov 7;83(12):ajvr.22.07.0120. doi: 10.2460/ajvr.22.07.0120.
2
Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.犬血管肉瘤细胞系中促凝血组织因子表达的评估
Am J Vet Res. 2017 Jan;78(1):69-79. doi: 10.2460/ajvr.78.1.69.
3
Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.犬血管肉瘤潜在分子治疗靶点的免疫组织化学检测
J Vet Med Sci. 2016 May 3;78(4):649-56. doi: 10.1292/jvms.15-0625. Epub 2015 Dec 21.
4
Luteinizing Hormone Receptor Expression in Neoplastic Mast Cells Is Increased in Spayed and Neutered Dogs.去势和绝育犬的肿瘤肥大细胞中黄体生成素受体表达增加。
J Am Anim Hosp Assoc. 2022 Nov 1;58(6):271-276. doi: 10.5326/JAAHA-MS-7150.
5
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.脂质体包裹的胞壁酰三肽磷脂酰乙醇胺佐剂免疫疗法治疗犬脾脏血管肉瘤:一项随机多机构临床试验
Clin Cancer Res. 1995 Oct;1(10):1165-70.
6
Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.一种新型肿瘤疫苗在患有血管肉瘤的犬类中的评估。
J Vet Intern Med. 2007 Jan-Feb;21(1):113-20. doi: 10.1892/0891-6640(2007)21[113:eoantv]2.0.co;2.
7
Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.聚乙二醇化脂质体包裹阿霉素腔内给药治疗犬脾脏血管肉瘤的临床及药代动力学特征
J Vet Intern Med. 2007 Nov-Dec;21(6):1347-54. doi: 10.1892/06-214.1.
8
Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.多柔比星和德拉考昔辅助治疗犬脾脏血管肉瘤:一项初步研究。
Can Vet J. 2013 Mar;54(3):237-42.
9
Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.持续低剂量口服化疗用于犬脾脏血管肉瘤的辅助治疗。
J Vet Intern Med. 2007 Jul-Aug;21(4):764-9. doi: 10.1892/0891-6640(2007)21[764:clocfa]2.0.co;2.
10
Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.内皮素抑制剂在犬血管肉瘤中的治疗潜力。
Life Sci. 2016 Aug 15;159:55-60. doi: 10.1016/j.lfs.2016.01.047. Epub 2016 Feb 1.

引用本文的文献

1
Differential Expression of LHR and FSHR in Canine Mammary Tumors: Correlation with Malignancy and Spay Status.犬乳腺肿瘤中促黄体生成素受体(LHR)和促卵泡激素受体(FSHR)的差异表达:与恶性程度及绝育状态的相关性
Vet Sci. 2025 May 19;12(5):496. doi: 10.3390/vetsci12050496.
2
Diagnostic and Prognostic Value of Blood Ratios in Canine Splenic Hemangiosarcoma: A Multicentric Observational Study.犬脾脏血管肉瘤血液比值的诊断和预后价值:一项多中心观察性研究
Vet Sci. 2025 Apr 9;12(4):346. doi: 10.3390/vetsci12040346.